Preclinical study of monoclonal antibodies for HIV provides strong basis for clinical trials in humans

A research team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a group of recently discovered antibodies may be a highly effective therapy for the treatment of HIV. Published on-line in the journal Nature, the findings encourage the development of these monoclonal antibodies as a novel therapy in humans... via Health News from Medical News Today Read More Here..